CRP and gastric cancer: Studies have suggested that the combination C-reactive protein (CRP), systemic inflammation response index (SIRI) and PLR not only predicts OS, relapse-free survival (RFS), but also significantly correlates with the degree of lymph node metastasis in GC (6).